- Home
- HES vs COR Comparison
HES vs COR Comparison
Compare HES & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HES
- COR
- Stock Information
- Founded
- HES 1920
- COR 2001
- Country
- HES United States
- COR United States
- Employees
- HES N/A
- COR N/A
- Industry
- HES Integrated oil Companies
- COR Other Pharmaceuticals
- Sector
- HES Energy
- COR Health Care
- Exchange
- HES Nasdaq
- COR Nasdaq
- Market Cap
- HES 41.4B
- COR 44.7B
- IPO Year
- HES N/A
- COR N/A
- Fundamental
- Price
- HES $147.48
- COR $243.21
- Analyst Decision
- HES Buy
- COR Buy
- Analyst Count
- HES 10
- COR 11
- Target Price
- HES $163.90
- COR $265.91
- AVG Volume (30 Days)
- HES 1.6M
- COR 1.3M
- Earning Date
- HES 10-30-2024
- COR 11-06-2024
- Dividend Yield
- HES 1.36%
- COR 0.86%
- EPS Growth
- HES 80.04
- COR N/A
- EPS
- HES 8.57
- COR 7.53
- Revenue
- HES $12,463,000,000.00
- COR $293,958,599,000.00
- Revenue This Year
- HES $23.99
- COR $8.69
- Revenue Next Year
- HES N/A
- COR $6.19
- P/E Ratio
- HES $17.21
- COR $32.24
- Revenue Growth
- HES 21.35
- COR 12.12
- 52 Week Low
- HES $123.79
- COR $195.83
- 52 Week High
- HES $163.98
- COR $251.56
- Technical
- Relative Strength Index (RSI)
- HES 70.07
- COR 57.01
- Support Level
- HES $144.83
- COR $237.48
- Resistance Level
- HES $147.65
- COR $244.29
- Average True Range (ATR)
- HES 2.43
- COR 4.93
- MACD
- HES 0.68
- COR -0.31
- Stochastic Oscillator
- HES 98.34
- COR 60.63
About HES Hess Corporation
Hess is an independent oil and gas producer with key assets in the Bakken Shale, Guyana, the Gulf of Mexico, and Southeast Asia. At the end of 2023, the company reported net proved reserves of 1.4 billion barrels of oil equivalent. Net production averaged 391 thousand barrels of oil equivalent per day in 2023, at a ratio of 74% oil and natural gas liquids and 26% natural gas.
About COR Cencora Inc.
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the us pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.